Physician profile
Michael Paikal
NPI 1508058371
$10,789.33
in general payments reported to CMS, 2019-2025
16 companies · $1,566 in 2025
The $1,566 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,048 · 2020: $76.33 · 2021: $847 · 2022: $437 · 2023: $475 · 2024: $341 · 2025: $1,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736 · Travel and Lodging: $630 · Entertainment: $15.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,736.07 |
| Travel and Lodging | $629.97 |
| Entertainment | $15.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,826.95 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Rotapro |
| Medical Device Business Services, INC. | $2,068.42 | 2019 | |
| Medtronic Vascular, INC. | $1,642.01 | 2019 | |
| Abbott Laboratories | $1,638.96 | 2019-2025 | Aveir, Ensite Precision, Cardiomems |
| Medtronic, INC. | $794.00 | 2021-2025 | Micra |
| Biosense Webster, INC. | $499.36 | 2019-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $352.55 | 2019-2025 | Lifevest |
| Biotronik INC. | $307.68 | 2019-2024 | Amvia Edge |
| Novartis Pharmaceuticals Corporation | $166.84 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $116.27 | 2023 | Camzyos |
| Kestra Medical Technology Services, INC. | $112.82 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $106.84 | 2022 | |
| Pfizer INC. | $95.34 | 2024-2025 | |
| Teleflex LLC | $26.63 | 2022 | |
| Bardy Diagnostics, INC. | $18.87 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $15.79 | 2023 | Optowire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Paikal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.